evolcSign in

Tandril SK

Diabetic retinopathy screening with AI-assisted analysis of retinal images for eye-care providers in Slovakia

Košice, SlovakiaFounded 2023tandril.sk

Highlights

  • Young companyFounded 2023
  • New on EvolcAdded 2026-10-17

About Tandril SK

Tandril SK s.r.o. distributes a certified medical device for diabetic retinopathy screening: the iCare DRSplus non-mydriatic confocal fundus camera, paired with the iCare RETCAD® AI screening software and the iCare ILLUME Connect cloud for storing and sharing reports.

The company sells to healthcare providers, including optics, pharmacies, polyclinics and hospitals, and to specialists doing eye-background screening. The website does not describe pricing or revenue model beyond the product offering.

Tandril SK was founded in 2023 as a Slovak subsidiary of Tandril, a.s., which the website says was set up in the Czech Republic in 2022. The website lists Košice as the seat; no other offices are named.

Product: iCare DRSplus confocal fundus camera combined with iCare RETCAD AI screening software for diabetic retinopathy detection.

Financials

FY2025FY2024FY20236 months
Revenue€49k€52k€14k
Growth−6%——
EBITDA−€14k−€14k−€8k
Operating profit−€14k−€14k−€8k
Net profit−€15k−€15k−€8k
Net margin−30.1%−29.3%−55.9%
Personnel costs€23k€23k€4k
Total assets€21k€44k€35k
Cash€16k€44k€35k
Liabilities€43k€52k€28k
Equity−€23k−€8k€7k

As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.

Open jobs

No open positions listed right now.

Tech stack

  • Apache
  • Bootstrap
  • Google Analytics 4
  • Google reCAPTCHA
  • PHP
  • jQuery